GlassScriptPhysician profile
Jason D Tu
NPI 1619902954
$350,585.22
in general payments reported to CMS, 2019-2025
33 companies · $55K in 2025
The $55K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $16K · 2021: $37K · 2022: $52K · 2023: $75K · 2024: $68K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $115K · Travel and Lodging: $37K · Consulting Fee: $31K · Food and Beverage: $15K · Entertainment: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $114,625.00 |
| Travel and Lodging | $37,239.38 |
| Consulting Fee | $31,287.50 |
| Food and Beverage | $15,040.44 |
| Entertainment | $453.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $239,957.34 | 2022-2025 | Infuse, Infuse Multifocal, Infuse Svs |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $96,075.12 | 2019-2021 | |
| Coopervision INC. | $3,217.18 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Abbvie INC. | $1,956.37 | 2022-2023 | Vuity, Lumigan, Alphagan P |
| Sight Sciences, INC. | $1,511.98 | 2019-2024 | Tearcare System |
| Alcon Vision LLC | $1,104.36 | 2021-2025 | Dailies, Clareon, Wavelight Refractive Suite |
| Glaukos Corporation | $711.78 | 2022-2024 | Radius Xr, Photrexa |
| Tarsus Pharmaceuticals, INC. | $627.31 | 2024-2025 | Xdemvy |
| Maculogix, INC. | $622.13 | 2019-2021 | |
| Optos, INC. | $563.98 | 2020-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lumenis Be INC | $515.07 | 2022-2024 | M22 |
| Lombart Brothers, INC. | $458.05 | 2020-2025 | Opd-III |
| Topcon Healthcare, INC. | $365.77 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $275.31 | 2019-2025 | |
| Oyster Point Pharma, INC. | $264.72 | 2023-2024 | Tyrvaya, Ryzumvi |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $264.00 | 2021-2022 | |
| Allergan, INC. | $261.21 | 2021-2022 | |
| Dompe US, INC. | $225.02 | 2022-2024 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $211.78 | 2020-2023 | Lipiflow System Activator (Disposable), Meibomian Gland Evaluator |
| Oculus, INC. | $189.73 | 2019 | |
| Harrow Eye, LLC | $168.86 | 2025 | Vevye |
| Kala Pharmaceuticals, INC. | $163.31 | 2021 | |
| Lkc Technologies, INC. | $127.92 | 2023-2025 | |
| Biotissue Holdings INC. | $122.01 | 2022 | |
| Ivantis, INC | $119.95 | 2021 | |
| Mallinckrodt Hospital Products INC. | $111.53 | 2021-2025 | Acthar |
| Visionix USA, INC | $98.82 | 2022 | |
| Abb Con-Cise Optical Group LLC | $85.21 | 2022-2024 | Spectacle Lenses, Contact Lens |
| Tearlab Corp | $66.23 | 2024 | Scoutpro Osmolarity System |
| Shire North American Group INC | $63.53 | 2019 | |
| Lumenis, INC | $47.92 | 2021 | |
| Optovue, INC. | $18.25 | 2019 | |
| Carl Zeiss Meditec, INC. | $13.47 | 2023 | Cirrus Hd-Oct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.